ST.
LOUIS, July 23, 2024 /PRNewswire/ -- Dr.
Thomas Wright, a leading expert in
the field of lipedema treatment, along with his esteemed
co-authors, is proud to announce that their manuscript, "Lipedema
Reduction Surgery Improves Pain, Mobility, Physical Function, and
Quality of Life: Case Series Report," has been awarded the 2024 PRS
Global Open Best Paper Award for "BEST RECONSTRUCTIVE PAPER."
The Editorial and Publishing staff of PRS Global Open
meticulously analyzed data from all manuscripts published in 2023,
considering the number of times each article was accessed on
PRSGlobalOpen.com and Ovid. This comprehensive review ensured an
unbiased selection process, with Dr. Wright's paper emerging as the
clear winner in the reconstructive category.
Summary of the Award-Winning Paper
The manuscript addresses the significant impact of Lipedema
Reduction Surgery (LRS) on patients with lipedema, a chronic
inflammatory subcutaneous adipose-rich connective tissue disease
affecting millions of women worldwide. The study is a retrospective
chart review of 189 women, with detailed analysis conducted on 66
women before and after undergoing LRS. The paper reports common
comorbidities such as hypermobile joints, spider/varicose veins,
arthritis, and hypothyroidism. The findings highlight significant
improvements in knee flexion, gait, patient-reported outcomes,
mobility, and overall quality of life post-surgery. These results
are comparable to those seen after total knee replacement.
About the Authors: Dr. Thomas
Wright and Dr. Karen
Herbst
Dr. Thomas Wright is the medical
director of Lipedema Surgical Solutions. He is a specialist in
Venous and Lymphatic Medicine. He has published half a dozen peer
reviewed papers on Lipedema and related fat diseases. Through his
research and practice, Dr. Wright continues to contribute to the
understanding of lipedema and the advancement of reconstructive
surgery.
Dr. Karen L. Herbst, a prominent
board-certified endocrinologist, is the Head of Research and
Director of Diagnostic and Preventative Medicine at The Roxbury
Institute, home to the Advanced Lipedema Treatment (ALT) program.
She is an internationally recognized authority on lipedema and
associated adipose disorders. She is the lead author of the US
Standard of Care Guidelines and has contributed to numerous other
highly regarded peer-reviewed publications on lipedema.
What is Lipedema:
Lipedema is a congenital connective tissue disease that affects
the subcutaneous tissue (adipose and surrounding tissue) primarily
in women. The exact cause of Lipedema is not known, but there is a
clear genetic predisposition. It can cause pain, swelling and
impair the mobility of the women with the disease. Untreated
lipedema can lead to secondary lymphedema and disability.
Quote:
"I am honored that our paper was chosen by the PRS Global Open
to be the most impactful reconstructive paper of 2023. I hope that
this recognition will spread awareness about the treatment option
of Lipedema Reduction Surgery LRS and the mobility and quality of
life benefits that LRS can offer for women with lipedema." Dr.
Thomas Wright.
The full paper is available for review at PRS
Global
Open. https://journals.lww.com/prsgo/fulltext/2023/11000/lipedema_reduction_surgery_improves_pain,.73.aspx
Media Contact:
For more information, please contact Dawn Simon at 636-397-4012 or
380661@email4pr.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/dr-thomas-wright-of-lipedema-surgical-solutions-and-dr-karen-herbst-of-alt-win-prestigious-2024-prs-global-open-best-paper-award-for-reconstructive-surgery-302202886.html
SOURCE Lipedema Surgical Solutions